The native token of the largest DeFi lending protocol is showing strong momentum despite short-term profit taking above $290.

XLM briefly pushed higher on Oct. 3 before sharp selling erased gains, highlighting resistance near $0.41 even as Bitcoin.com Wallet integration expands Stellar’s reach.

Hedera’s native token slid 3.6% over 23 hours, with heavy institutional selling pushing prices below key support levels ahead of a potential SEC ETF decision.

The price has dipped back to $2.43, with support just underneath.

Binance set a record $2.63 trillion in futures trading volume in August. BNB can be used for trading fee discounts on the exchange.

The CoinDesk Memecoin Index (CDMEME) rose more than 11% in the week, outperforming bitcoin’s 1.4% move.

Corporate trading desks increased exposure as volume surged 85% to $333.21 million, though regulatory uncertainties persist around stablecoin framework implementation.

Hedera’s token tumbled from $0.22 to $0.21 as selling pressure, profit-taking and broader market weakness drove traders out of risk assets.

Token faces critical support test amid massive liquidations and weakening institutional demand across major exchanges.

The Polkadot token tumbled amid increased selling pressure as support levels failed.

Network activity has declined, with daily active addresses dropping to fewer than 3,000, and technical analysis suggesting a possible 15% drop.

The token’s rejection at $0.26 came amid a broad crypto pullback, with the CoinDesk 20 Index sliding 4% and rate-cut hopes fading.

ChatGPT said:

NEAR Protocol swung between $2.78 and $3.05 as nearly 20 million tokens changed hands during peak sell pressure, before buyers stepped in to lift prices back toward $2.82.

ATOM-USD rebounded sharply from a midday selloff, with heavy volume and fresh support at $4.60 signaling renewed buyer confidence, even as resistance at $4.91 remains unbroken.

Despite the price decline, whale accumulation of PEPE continued, with the top addresses on Ethereum increasing their holdings by 1.5% in the last 30 days.

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

The token has significant support in the $3.87-$3.93 range, with resistance at the $4.11 level.